Work

Supplementary Table S1 from UM-164: A Potent c-Src/p38 Kinase Inhibitor with In Vivo Activity against Triple-Negative Breast Cancer

Year: 2023

Type: supplementary-materials

Abstract: Kinome-wide profiling data of UM-164 and dasatinib in MDA-MB 231 lysate

DOI: 10.1158/1078-0432.22458360

Authors: Rabia A. Gilani, Sameer Phadke, Li Wei Bao, Eric J. Lachacz, Michele L. Dziubinski, Kristoffer R. Brandvold, Michael E. Steffey, Frank E. Kwarcinski, Carrie R. Graveel, Kelley M. Kidwell, Sofia D. Merajver, Matthew B. Soellner

Language: English

Topic: Cancer Mechanisms and Therapy

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362434810

Cites:

Cited by:

Related to: 10